Issue Navigation
-
Editorial
-
236-239
Challenges in Japan's dual systems of support for pediatric and adult intractable diseases
Karako K, Song PP
Intractable Rare Dis Res. 2025; 14(4):236-239.
DOI: 10.5582/irdr.2025.01067
-
240-248
A scoping review of dietary interventions to treat obesity among Prader-Willi syndrome individuals
Aman M, Abdul Hamid H, Rajikan R
Intractable Rare Dis Res. 2025; 14(4):240-248.
DOI: 10.5582/irdr.2025.01029
-
249-257
Mitochondrial DNA A3243G variant: Current perspectives and clinical implications
Chu KY
Intractable Rare Dis Res. 2025; 14(4):249-257.
DOI: 10.5582/irdr.2025.01051
-
258-265
Yang LC, Wang Y, Yuan LW, Tang W
Intractable Rare Dis Res. 2025; 14(4):258-265.
DOI: 10.5582/irdr.2025.01080
-
266-276
Wang Q, Guo L, Yang Y, He J
Intractable Rare Dis Res. 2025; 14(4):266-276.
DOI: 10.5582/irdr.2025.01025
-
277-287
Zhang H, Wei Y, Sun Y, Zhang Y, Wang Z, Zou H, Da Y, Zhao Z, Zhang Z, Wu G, Zhao W, Tian C, Yan C, Wang C, Zhao Y
Intractable Rare Dis Res. 2025; 14(4):277-287.
DOI: 10.5582/irdr.2025.01054
-
288-296
Factors associated with diagnostic delays in Peruvian patients with rare diseases
Falen SolĂs AM, Abarca Barriga HH
Intractable Rare Dis Res. 2025; 14(4):288-296.
DOI: 10.5582/irdr.2025.01052
-
297-302
Zhang RH, Chen X, Wang ZY, Xu C, Li SH
Intractable Rare Dis Res. 2025; 14(4):297-302.
DOI: 10.5582/irdr.2025.01033
-
303-305
Shu HY, Shang XH, Sun Y, Li GM, Chen C, Yang JM
Intractable Rare Dis Res. 2025; 14(4):303-305.
DOI: 10.5582/irdr.2025.01053
-
306-308
AI-driven enhancements in rare disease diagnosis and support system optimization
Wang X, He D, Jin CL
Intractable Rare Dis Res. 2025; 14(4):306-308.
DOI: 10.5582/irdr.2025.01079
Summary
Full Text (PDF)




